The QDPR gene helps recycle a helper molecule called tetrahydrobiopterin, which your body needs to make brain chemicals like dopamine and serotonin and to process phenylalanine from food. If this gene does not work properly, phenylalanine can build up and the brain may not get enough of these signaling chemicals. This can lead to feeding problems, low muscle tone, developmental delay, movement symptoms, or seizures. Pathogenic variants in the QDPR gene cause a rare inherited condition called dihydropteridine reductase deficiency.
What is a gene?
A gene is a stretch of DNA that holds instructions your cells use to make molecules or guide processes in the body. Some genes provide the directions for producing proteins, which are the active parts of cells. Others are used mainly to regulate when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, or medicines. For a deeper look at this subject, you can read more in the LearnHub.
Overview
QDPRGene function
What if the gene works
The QDPR gene helps recycle a helper molecule your body needs to process phenylalanine, an amino acid from food. This also supports the making of brain messengers such as dopamine and serotonin.
Risk
What if the gene does not work
Variants in the QDPR gene can cause dihydropteridine reductase deficiency, leading to high phenylalanine levels and low brain chemical signals. Features often include developmental delay, movement problems, or seizures, and milder versus more severe variants can change timing and severity.
Treatment
What does that mean for your treatment
Pathogenic variants in the QDPR gene usually shift treatment toward neurotransmitter replacement, most often levodopa with carbidopa and 5-hydroxytryptophan, often with folinic acid. A low-phenylalanine diet may also be used to help control phenylalanine levels. Sapropterin is generally not the main treatment in QDPR deficiency because the recycling step is impaired.
Conditions associated with QDPR
Gene function
What if the gene works
Your cells use the QDPR gene to recycle tetrahydrobiopterin, often called BH4, a small helper molecule used in several key body processes. When BH4 is refreshed, enzymes can keep working in a steady way. This supports amino acid handling, chemical signaling in the brain, and normal nitric oxide production.
The protein made from the QDPR gene turns used BH4 back into its active form. This lets the same helper molecule be reused in many routine cell reactions.
Recycled BH4 helps the body process phenylalanine, a building block from protein in food. This is part of how the QDPR gene helps break down phenylalanine in the body.
By keeping BH4 available, the QDPR gene supports enzymes that make dopamine and serotonin. These chemical messengers help with movement, mood, attention, and other day to day brain functions.
BH4 is also needed to make nitric oxide, a signal that helps blood vessels relax and supports steady blood flow. This means the QDPR gene contributes to routine signaling in blood vessels and other tissues.
What is a variant?
A genetic variant is a small alteration in the DNA sequence of a gene. These changes are common and contribute to normal differences among people, such as appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can more substantially change how a gene functions and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the QDPR gene can change the enzyme’s shape, stability, or ability to work, so cells cannot efficiently recycle tetrahydrobiopterin, a helper molecule several enzymes need. In practical terms, this is how QDPR gene variants can reduce enzyme activity inside cells. Milder variants may leave some residual activity, while more severe variants can leave very little or none, which often relates to earlier onset and a broader or more pronounced pattern of symptoms in dihydropteridine reductase deficiency.
How variants are linked to conditions
Pathogenic variants in the QDPR gene cause dihydropteridine reductase deficiency, also called DHPR deficiency, a rare inherited condition. In this QDPR gene variants linked to conditions overview, the main established association is with high phenylalanine levels on newborn screening and, without treatment, problems such as developmental delay, seizures, movement symptoms, and muscle stiffness. A confirmed disease-causing QDPR variant can establish the genetic diagnosis.
A variant is not necessarily a diagnosis
Gene variants are a normal feature of human biology and are common throughout the general population. Most do not have a direct effect on health and simply represent natural variation among people. For many genes, carrying a variant associated with a condition indicates a possible link rather than a confirmed diagnosis, especially when multiple genes and environmental factors also contribute. In some cases, though, a single well understood variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For QDPR, risk is mainly determined by the gene changes inherited from both parents rather than by lifestyle or environmental factors. Many living with QDPR have this condition only when both copies of the gene are changed, so family history and whether parents are carriers matter most.
Inheritance of QDPR variants
QDPR-related conditions are inherited in an autosomal recessive pattern, which means a child usually needs to inherit one changed copy of the QDPR gene from each parent. Parents who each carry one variant are often healthy themselves, but with each pregnancy there is a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with two working copies. This explains how QDPR gene variants are inherited in families and why they can appear in a child even when there is no family history of symptoms.
What does my QDPR result mean for my family?
For families affected by a QDPR-related condition, close relatives may also carry the changed gene, even if they feel well. Brothers and sisters may also be affected or be carriers, and relatives planning children may want to learn whether they carry the same change. This matters most for biological family members on both sides of the family.
Genetic information
Genetic testing
How you find out about variants
Genetic testing to find QDPR variants usually uses a blood or saliva sample and reads the QDPR gene for spelling changes. It can show whether a person has two pathogenic variants linked to this condition or carries one variant, and results are often reviewed alongside symptoms and lab findings.
When should I consider getting a genetic test?
Consider genetic testing for the QDPR gene if a newborn screen shows high phenylalanine, if a child has signs of this rare inherited condition, or if there is a family history of it. Testing can help confirm the diagnosis and show whether relatives carry the same gene change.
A genetic result is only one part of your health story
A genetic finding can offer meaningful insight, though how much it explains depends on the condition and on the type of variant involved. Over time, the way the body works is shaped by many influences, including lifestyle, environment, age, and medical history. With some conditions, particularly those influenced by many genes, genetic information adds context rather than certainty and is best understood along with other aspects of care. In other cases, it may give a clear answer. In areas like medication response, genetic results can help place individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, has less effect in another, or causes more side effects in someone else. Differences in how the body absorbs, breaks down, transports, or responds to a drug are common and can influence both benefit and sensitivity.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences shape the way people respond to medications. It studies gene and drug patterns to help explain why the same treatment may work differently from one person to another. For many medicines, genes affect how strongly a drug works or how the body handles it. This information can support more informed, personalized treatment decisions. To explore this topic in greater detail, you can learn more in LearnHub.
Drugs influenced by the QDPR gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding routine medication choices, so general questions about side effects, new symptoms, or how medicines may affect you are best discussed with your doctor. QDPR has mainly been studied in the rare condition it causes and in response to treatments linked to that condition, rather than as a standard guide for common prescribing.
History
QDPR entered medical genetics through studies of children with high phenylalanine levels who did not fit the usual pattern of classic phenylketonuria. In the 1970s and 1980s, researchers began separating different causes of these cases and identified deficiency of dihydropteridine reductase as a distinct condition. From these first observations, research expanded steadily. As DNA studies advanced, variants in the QDPR gene were confirmed as the cause in affected families, making diagnosis more precise. This helped newborn screening programs and specialist testing distinguish QDPR related disease from other forms of hyperphenylalaninemia. Over time, the QDPR gene became an established part of the history of inherited metabolic conditions, mainly within specialist care rather than public awareness.